Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Journal of Neurosurgery|October 7, 2005
Malignant prolactinoma with multiple bone and pulmonary metastases. Case reportCristina Lamas, Raúl Núñez, José García-Uría, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2004
Re-innervation after heart transplantation: a multidisciplinary studyJuan Carlos Gallego-Page, Javier Segovia, Luis Alonso-Pulpón, et al.JACC. Case Reports|April 20, 2023
Danon Disease Presenting as Eosinophilic Myocarditis: Key Role of Endomyocardial BiopsyBasilio Angulo-Lara, Ramón Garrido-González, Clara Salas Antón, et al.Critical Care (London, England)|October 18, 2022
Individualizing mechanical ventilation: titration of driving pressure to pulmonary elastance through Young's modulus in an acute respiratory distress syndrome animal modelÁlvaro Mingote, Ramsés Marrero García, Martín Santos González, et al.Medical Mycology Case Reports|May 26, 2016
Scedosporium apiospermum and S. prolificans mixed disseminated infection in a lung transplant recipient: An unusual case of long-term survival with combined systemic and local antifungal therapy in intensive care unitBárbara Balandin, Miriam Aguilar, Isabel Sánchez, et al.Medical Oncology (Northwood, London, England)|April 13, 2013
Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumabIrene Guijarro-Muñoz, Antonio Sánchez, Esther Martínez-Martínez, et al.Revista Espanola De Cardiologia|June 2, 2009
Cardiac amyloidosis: the importance of a multidisciplinary approachManuel Gómez-Bueno, Javier Segovia, Pablo García-Pavía, et al.Revista Espanola De Cardiologia (English Ed.)|April 3, 2012
Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtypeF Javier de Haro-del Moral, Alicia Sánchez-Lajusticia, Manuel Gómez-Bueno, et al.Journal of Clinical Pathology|March 16, 2021
Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP)Clara Salas, Javier Martín-López, Antonio Martínez-Pozo, et al.Journal of Clinical Pathology|December 14, 2021
Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP)Javier Martín-López, Federico Rojo, Antonio Martínez-Pozo, et al.Pageof 7